OMER CIK: 1285819

Omeros Corp.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
248
FY22:
443
FY23:
218
FY24:
134
FY25:
216
(positive)
Change from FY21 to FY25
millions USD
FY21:
171
FY22:
148
FY23:
160
FY24:
143
FY25:
110
Total assets
Change from FY21 to FY25
millions USD
FY21:
419
FY22:
591
FY23:
378
FY24:
277
FY25:
326

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
51.8
FY22:
136
FY23:
53.3
FY24:
79.5
FY25:
78.1
(negative)
Change from FY21 to FY25
millions USD
FY21:
344
FY22:
369
FY23:
–
FY24:
380
FY25:
369
(positive)
Change from FY21 to FY25
millions USD
FY21:
23.8
FY22:
85.7
FY23:
−25.0
FY24:
−183
FY25:
−121
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
419
FY22:
591
FY23:
–
FY24:
277
FY25:
326

All amounts in millions USD Data sources:SEC EDGARTwelve Data